Linagliptin as Add on Therapy to Empagliflozin 10 mg or 25 mg With Japanese Patients With Type 2 Diabetes Mellitus

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 880 participants.

Also called NCT02489968

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 880 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02489968
Other papers using this trial's data
  • Linagliptin as add-on to empagliflozin in a fixed-dose combination in Japanese patients with type 2 diabetes: Glycaemic efficacy and safety profile in a two-part, randomized, placebo-controlled trial Diabetes, obesity & metabolism, 2019-01 DOI, PubMed 30091172, PMC6585831 In the PMC Open Access subset under CC BY-NC.

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
Japan (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02489968. Randomized; double masking; primary purpose treatment. Start 2015-05-12 (actual); primary completion 2016-11-18 (actual). Results posted on 2018-09-06.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Linagliptin as Add on Therapy to Empagliflozin 10 mg or 25 mg With Japanese Patients With Type 2 Diabetes Mellitus
Condition
Diabetes Mellitus, Type 2
Intervention (Drug)
empagliflozin 10 mg + linagliptin 5 mg
Intervention (Drug)
empagliflozin 10 mg
Intervention (Drug)
empagliflozin 25 mg + linagliptin 5 mg
Intervention (Drug)
empagliflozin 25 mg
Intervention (Drug)
Placebo
Lead sponsor
Boehringer Ingelheim (class: industry)
Collaborator
Eli Lilly and Company (class: industry)

Record details

Record id
cardio:ct-nct02489968
Content hash
ca71ef9c1af9737946185346a5afac7db70ac5a248dfc6b09d66f0fe501e890b